Affiliations: [a]
Sechenov First Moscow State Medical University, Tareev Clinic of Internal Diseases,. Rossolimo Moscow, Russia
| [b]
Lomonosov Moscow State University, Faculty of Medicine, Moscow, Russia
| [c]
National Medical Research Center for Therapy and Preventive Medicine, Moscow, Russia
Correspondence:
[*]
Corresponding author: Natalia Chebotareva, Sechenov First Moscow State Medical University, Tareev Clinic of Internal Diseases, Rossolimo 11/5, 119435 Moscow, Russia. Tel.: +79055434250; Fax: +74992484166; E-mail: [email protected].
Abstract: Nephrotic syndrome (NS) is associated with a high risk for venous and arterial thrombosis due to hypercoagulability. Integral tests designed to assess hemostasis can become an alternative for measuring hypercoagulability in patients with NS. STUDY OBJECTIVE:To assess hemostatic disorders in CGN patients complicated by NS using the thrombodynamics test. MATERIALS AND METHODS:The study included 60 adult patients with chronic glomerulonephritis (CGN), mean age 37 years, 31 (52%) women, and 29 (48%) men. Among all patients, 53 % of patients had NS, 47 % had no sign of NS. Hemostasis was assessed using the thrombodynamics test. The results were compared with biochemical parameters, which are usually associated with NS and renal dysfunction. RESULTS:According to the thrombodynamics test, CGN patients with NS demonstrated a tendency to hypercoagulability: increased rates of V (rate of clot growth), increased D (clot density), and increased CS (clot size) after 30 minutes. A positive correlation of these parameters with the serum albumin, creatinine levels, and glomerular filtration rate (GFR) indicates the influence of severe NS and renal dysfunction on the hemostasis activation in CGN patients with NS. CONCLUSION:According to the thrombodynamics test, CGN patients with NS demonstrate increased rates of clot formation, increased clot size after 30 minutes, and increased clot density due to secondary hemostasis activation. These changes positively correlate with the severity of hypoalbuminemia, hypercholesterolemia, and renal dysfunction in NS patients.
